SatterwhiteCL, TorroneE, MeitesE, et al.Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sex Trans Dis, 2013; 40:187–193.
2.
American College of Obstetricians and Gynecologists. Practice bulletin No. 168: Cervical cancer screening and prevention. Obstet Gynecol, 2016; 128:111–130.
3.
WalboomersJM, JacobsMV, ManosMM, et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999; 189:12–19.
4.
McQuillanG, Kruszon-MoranD, MarkowitzL, UngerE, Paulose-RamR.Prevalence of HPV in adults aged 18–69: United States, 2011–2014. NCHS data brief, no. 280. Hyattsville, MD: National Center for Health Statistics, 2017.
5.
American College of Obstetricians and Gynecologists. Practice Bulletin No. 140: Management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol, 2013; 122:1338.
6.
WalkerTY, Elam-EvansLD, YankeyD, et al.National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2017. Morb Mortal Wkly Rep, 2018; 67:909.
7.
LoweryC, QuirkJ, HanL, et al.Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes, 1997; 14:13–17.
8.
ZuoZ, GoelS, CarterJE. Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth. Am J Clin Pathol, 2011; 136:260–265.
9.
GomezL, MaY, HoC, McGrathC, NelsonD, ParryS. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod, 2008; 23:709–715.
10.
YouH, LiuY, AgrawalN, et al.Multiple human papillomavirus types replicate in 3A trophoblasts. Placenta, 2008; 29:30–38.
11.
McDonnoldM, DunnH, HesterA, et al.High risk human papillomavirus at entry to prenatal care and risk of preeclampsia. Am J Obstet Gynecol, 2014; 210:138.e131–138.e135.
12.
HongJN, BerggrenEK, CampbellSL, SmithJS, RahangdaleL. Abnormal cervical cancer screening in pregnancy and preterm delivery. Paediatr Perinat Epidemiol, 2014; 28:297–301.
13.
MillerES, SakowiczA, GrobmanWA. The association between cervical dysplasia, a short cervix, and preterm birth. Am J Obstet Gynecol, 2015; 213:543.e541–543.e544.
14.
SubramaniamA, LeesBF, BeckerDA, TangY, KhanMJ, EdwardsRK. Evaluation of human papillomavirus as a risk factor for preterm birth or pregnancy-related hypertension. Obstet Gynecol, 2016; 127:233–240.
15.
NimrodiM, KleitmanV, WainstockT, et al.The association between cervical inflammation and histologic evidence of HPV in PAP smears and adverse pregnancy outcome in low risk population. Eur J Obstet Gynecol Reprod Biol, 2018; 225:160–165.
16.
CaballeroA, DudleyD, FergusonJ, PettitK, BoyleA.Maternal human papillomavirus and preterm premature rupture of membranes: A retrospective cohort study. J Womens Health, 2019 [Epub ahead of print]; DOI: 10.1089/jwh.2018.7043.
17.
ChoG, MinK-J, HongH-R, et al.High-risk human papillomavirus infection is associated with premature rupture of membranes. BMC Pregnancy Childbirth, 2013; 13:173.
18.
HornychovaH, KacerovskyM, MusilovaI, et al.Cervical human papillomavirus infection in women with preterm prelabor rupture of membranes. PLoS One, 2018; 13:e0207896.
HargerJH, HsingAW, TuomalaRE, et al.Risk factors for preterm premature rupture of fetal membranes: A multicenter case-control study. Am J Obstet Gynecol, 1990; 163:130–137.
21.
ParryS, StraussJF. Premature rupture of the fetal membranes. New Engl J Med, 1998; 338:663–670.
22.
LiuL, OzaS, HoganDet al.Global, regional, and national causes of under-5 mortality in 2000–15: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet, 2016; 388:3027–3035.
23.
LawtonB, HoweAS, TurnerN, et al.Association of prior HPV vaccination with reduced preterm birth: A population based study. Vaccine, 2018; 36:134–140.
